Invacare Corporation (IVC) Position Raised by Keeley Teton Advisors LLC

Keeley Teton Advisors LLC increased its position in shares of Invacare Corporation (NYSE:IVC) by 1,779.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 442,715 shares of the health services provider’s stock after purchasing an additional 419,155 shares during the quarter. Keeley Teton Advisors LLC owned 1.13% of Invacare worth $6,973,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of IVC. Leucadia National Corp acquired a new stake in Invacare during the 2nd quarter valued at approximately $161,000. Goldman Sachs Group Inc. grew its position in shares of Invacare by 326.4% during the 2nd quarter. Goldman Sachs Group Inc. now owns 723,650 shares of the health services provider’s stock worth $9,552,000 after buying an additional 553,954 shares during the period. Koch Industries Inc. acquired a new stake in shares of Invacare during the 2nd quarter worth approximately $255,000. Northern Trust Corp grew its position in shares of Invacare by 1.8% during the 2nd quarter. Northern Trust Corp now owns 432,109 shares of the health services provider’s stock worth $5,705,000 after buying an additional 7,536 shares during the period. Finally, Vanguard Group Inc. grew its position in shares of Invacare by 3.8% during the 2nd quarter. Vanguard Group Inc. now owns 2,934,593 shares of the health services provider’s stock worth $38,736,000 after buying an additional 107,359 shares during the period. 94.65% of the stock is owned by hedge funds and other institutional investors.

In related news, SVP Dean J. Childers sold 6,249 shares of the stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $15.15, for a total value of $94,672.35. Following the transaction, the senior vice president now directly owns 44,875 shares in the company, valued at approximately $679,856.25. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 2.60% of the stock is owned by company insiders.

Shares of Invacare Corporation (IVC) remained flat at $$17.05 on Thursday. The company’s stock had a trading volume of 279,300 shares, compared to its average volume of 493,918. Invacare Corporation has a 12-month low of $9.90 and a 12-month high of $17.95. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.28 and a quick ratio of 1.57.

Invacare (NYSE:IVC) last issued its earnings results on Tuesday, November 7th. The health services provider reported ($0.41) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.43) by $0.02. Invacare had a negative return on equity of 13.33% and a negative net margin of 7.95%. The company had revenue of $250.91 million for the quarter, compared to analysts’ expectations of $239.88 million. During the same period last year, the business earned ($0.37) EPS. Invacare’s quarterly revenue was down 6.4% compared to the same quarter last year. analysts predict that Invacare Corporation will post -2 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, January 16th. Investors of record on Thursday, January 4th will be issued a $0.0125 dividend. This represents a $0.05 dividend on an annualized basis and a dividend yield of 0.29%. The ex-dividend date is Wednesday, January 3rd. Invacare’s dividend payout ratio is currently -2.13%.

Several analysts have recently commented on the stock. KeyCorp reaffirmed an “overweight” rating and set a $17.00 price objective on shares of Invacare in a research report on Tuesday, September 26th. Zacks Investment Research raised shares of Invacare from a “sell” rating to a “hold” rating in a research report on Wednesday, October 11th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $15.00.

TRADEMARK VIOLATION NOTICE: This piece was first posted by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international trademark & copyright law. The original version of this piece can be accessed at https://www.thelincolnianonline.com/2017/12/07/invacare-corporation-ivc-position-raised-by-keeley-teton-advisors-llc.html.

Invacare Profile

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific.

Institutional Ownership by Quarter for Invacare (NYSE:IVC)

Receive News & Ratings for Invacare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply